Press Releases

Date Title and Summary Additional Formats
Toggle Summary Omnicell To Present At The 30th Annual Piper Jaffray Healthcare Conference
MOUNTAIN VIEW, Calif. , Nov. 14, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL) a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps , founder, chairman, president and CEO, and Peter Kuipers...
View HTML
Toggle Summary Omnicell Achieves Record Revenue in the Third Quarter 2018
GAAP revenues of $204 million, up 9.4% year-over-year GAAP net income per diluted share of $0.33, up 65% year-over-year Non-GAAP revenues of $204 million, up 9.2% year-over-year Non-GAAP net income per diluted share of $0.63, up 37% year-over-year MOUNTAIN VIEW, Calif. , Oct....
View HTML
Toggle Summary Omnicell to Release Third Quarter 2018 Earnings Results on October 25, 2018
MOUNTAIN VIEW, Calif. , Oct. 18, 2018 /PRNewswire/ --  Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, October 25, 2018 , to discuss the Company's...
View HTML
Toggle Summary Omnicell Announces Second Quarter 2018 Results
GAAP revenues of $189 million, up 4.2% year-over-year GAAP net income per diluted share of $0.16, up $0.11 year-over-year Non-GAAP revenues of $189 million, up 4.0% year-over-year Non-GAAP net income per diluted share of $0.46, up $0.13 year-over-year MOUNTAIN VIEW, Calif....
View HTML
Toggle Summary Omnicell to Release Second Quarter 2018 Earnings Results on July 26, 2018
MOUNTAIN VIEW, Calif. , July 19, 2018 /PRNewswire/ --   Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, July 26, 2018 to discuss the Company's Second...
View HTML
Toggle Summary Omnicell Announces First Quarter 2018 Results
GAAP revenue of $183 million, up 23% year-over-year GAAP net income per diluted share of $0.07, up $0.35 year-over-year Non-GAAP revenue of $183 million, up 23% year-over-year Non-GAAP net income per diluted share of $0.29, up $0.22 year-over-year MOUNTAIN VIEW, Calif....
View HTML
Toggle Summary Omnicell to Release First Quarter 2018 Earnings Results on April 26, 2018
MOUNTAIN VIEW, Calif. , April 19, 2018 /PRNewswire/ --   Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, April 26, 2018 , to discuss the Company's...
View HTML
Toggle Summary Omnicell To Present At Needham & Company's 17th Annual Healthcare Conference
MOUNTAIN VIEW, Calif. , March 22, 2018 /PRNewswire/ --  Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at Needham & Company's 17 th Annual Healthcare Conference at the...
View HTML
Toggle Summary Omnicell Reports Results for Fiscal Year and Fourth Quarter 2017
Record yearly GAAP revenue of $716.2 million<br>Record yearly Non-GAAP revenue of $717.4 million<br>2017 GAAP net income per diluted share of $0.53<br>2017 Non-GAAP net income per diluted share of $1.33<br>Record ending product backlog of $345 million...
View HTML
Toggle Summary Omnicell to Release Fourth Quarter 2017 Earnings Results on February 1, 2018
MOUNTAIN VIEW, Calif. , Jan. 25, 2018 /PRNewswire/ --   Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, February 1, 2018 , to discuss the Company's...
View HTML